InvestorsHub Logo
Followers 24
Posts 5031
Boards Moderated 0
Alias Born 09/27/2005

Re: CTMedic post# 161026

Friday, 04/23/2021 8:04:11 AM

Friday, April 23, 2021 8:04:11 AM

Post# of 232960
Connecticut Medic, are you in agreement that if one IV dose of leronlimab had been the first dose administered followed by three successive weeks of subQ doses that CD 12 would have been a resounding success not only in the critical population, but also among the patients in severe condition and that the trial on the whole would have had results warranting the granting of EUA?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News